KLSE (MYR): DXN (5318)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.51
Today's Change
+0.01 (2.00%)
Day's Change
0.505 - 0.515
Trading Volume
2,095,800
Ann. Date | Name | Details of Changes | Securities After Changes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Date | Type | No. of Shares | Price | Direct (%) | Indirect (%) | Total (%) |
Brazil is the seventh most populous country in the world, and has decent PPP. Therefore, their recent expansion in Brazil will further drive long-term value creation for the company.
3 weeks ago
Yup, and Brazil's economy has experienced robust growth !
https://www.brasildefato.com.br/2024/12/04/investment-and-consumption-put-brazil-among-the-countries-with-highest-growth-rate
3 weeks ago
DXN is most likely to reward the shareholders with growing dividend considering that they have consistent profit and cashflow generation.
2 weeks ago
You obviously missed the boat, speakup. The train has left the station and resumed its upward trend 😁
2 weeks ago
can Q 45 sen, sure can. just that it would take years to match, or maybe NEVER.
2 weeks ago
DXN expanding into more markets is exciting. Every new country is a chance for more sales and bigger profits.
2 weeks ago
Sales momentum will continue in key markets, particularly Latin America, India and Turkey
2 weeks ago
DXN’s focus on emerging markets is a genius move. There’s so much potential for growth in those regions.
2 weeks ago
Not to mention their product margins are impressive. High profits mean they have more room to grow and invest back into the business.
2 weeks ago
1. After a month of decline from 60sen to an intra day low of 44.5sen, DXN has finally managed to recover some loss ground and made some recovery in its daily closing prices.
2 There were evidence of fresh buying. And last week with the support of new buying interest together with the 96m shares that changed hands over direct business transaction ( director buying ) the counter was able to see some light at the end of the tunnel. The bulls had returned and the closing prices had managed to close above 50 sen and sustained for 5 consecutive days.
3.Suffocation is gone and long term investors can now breathe. The pain that still remain has somewhat eased.
4. DXN continues to make remarkable and commendable performance in its daily price performance. Basing on the candlesticks chart, DXN has successfully established a GOLDEN CROSS yesterday on 11/12/2024 in which the 9-day moving average line has successfully crossed over the 26-day moving average line from below to above at 49.5 sen This is a most welcoming technical sign after a big fall.
5. The daily closing price had been moving faster than both the average lines. In addition, the closing prices for the last five 5 days had consistently closed above the golden cross. And that is truly impressive.
6. A golden cross is a bullish indicator and generally investors view this chart pattern as indicative of the beginning of a strong bull market. Perhaps, in the case of DXN be view as a reversal pattern from bearish to bullish.
7. If you trade according to and guided by technical analysis, the golden cross present the most opportune timing to buy.
Nonetheless, this is my personal and layman perception and opinion of the counter. It is not a recommendation to buy or sell. It is not intended to influence you investment decision and strategy.
8. The discussion and analysis is continuing.
Happy trading
12/12/2024
1 week ago
The quality of DXN's earnings is remarkable. Worth a long-term investment
1 week ago
DXN’s been around for years, and they’re still growing strong. Feels like a low-risk, high-reward stock.
1 week ago
DXN’s MLM model might not be everyone’s cup of tea, but it’s proven to work. Their distributors are growing their business and DXN’s revenue at the same time.
1 week ago
The MLM business model has proven to be effective, serving as a successful strategy to consistently increase sales and uphold the company's reputation through word-of-mouth marketing
1 week ago
Not to mention their presence in over 180 countries, this kind of global reach gives them a massive customer base to tap into
1 week ago
In this negative sentiment market, it is best to hold on tight. Don't be easily influenced when holding good stocks
1 week ago
They’re putting a lot of focus on e-commerce platforms. It’s smart, especially with more people shopping online these days.
1 week ago
Their investment in manufacturing plants is a good sign, means they’re preparing to meet rising demand head-on.
1 week ago
Successful penetration into markets such as Brazil is expected to contribute positively to DNX's long-term revenue growth 😉
6 days ago
Intrinsic value at Rm 1.46 according to snowflake analysis.
I prev bought at 0.63 and didn sold when its 0.68. I will keep topping up at 0.50. Anybody can say whatever they want but the numbers don't lie. Still good fundamentals. Long term investment with great dividends.
5 days ago
1. Intrinsic value of Rm 1.46 is over ambitious and even somewhat illogical.
2. DXN is now trading at 50sen and hence, it must soar 200%.
It would be great if you could write an analysis to show and outline the basis of arriving at 1.46
3. Would greatly appreciate and look forward to you attitude of sharing, learning and earning together.
4. Kindly enlighten us.
21/12.24
5 days ago
According to Alpha Spread, the intrinsic value of DXN is RM1.36. How to get RM1.46 ...?
3 days ago
@trader808 i think the analysis is done using the classic dcf valuation model, hence why the intrinsic value is "illogical". it is pretty common to see that because they discount all the upcoming 10 years free cash flow plus the terminal value of the business.
3 days ago
Monday, 25 Nov 2024
5:09PM
DXN DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS)
5:09PM
DXN LIM SIOW JIN (16,000,000 units Acquired)
5:09PM
DXN LIM SIOW JIN (16,000,000 units Acquired)
Thursday, 21 Nov 2024
5:11PM
DXN 500,000 shares purchased into treasury
Friday, 15 Nov 2024
1:31PM
DXN TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
Thursday, 14 Nov 2024
5:14PM
DXN DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS)
5:14PM
DXN LIM SIOW JIN (79,000,000 units Acquired)
5:14PM
DXN LIM SIOW JIN (79,000,000 units Acquired)
2 days ago
Price Target
A price target is an analyst's projection of a share's future price.
Average Target Price, Price Call and Upside/Downside here are derived from Price Targets in the past 6 months.
Last Price
0.50
Avg Target Price
0.91
Upside/Downside
+0.41 (82.00%)
2 days ago
DXN Holdings - Cost Inflations Weigh on Earnings; Stay BUY
Date:
2024-10-25
Firm:
RHB-OSK
Stock:
DXN
Price Target:
0.88
Price Call:
BUY
Last Price:
0.50
Upside/Downside:
+0.38 (76.00%)
Maintain BUY with new MYR0.88 TP from MYR0.93, 49% upside and c.7% FY26F yield. DXN Holdings’ 1HFY25 (Feb) missed estimates due to higher- than-expected costs and unfavourable FX. That said, the strategies to deepen penetration in existing markets and new market expansion should continue to foster growth, supplemented by new product launches. Valuation remains attractive considering the effective business model, Brazil expansion as a medium-term growth driver, and sturdy balance sheet (1HFY25 net cash: MYR521m or 10.5 sen/share) to facilitate a generous dividend pay-out.
DXN’s 1HFY25 results were below expectations. Core net profit of MYR148m (-14% YoY) met 39-40% of our and consensus’ forecasts due to higher-than-expected staff and shipping costs as well as unfavourable FX. Post results, we cut FY25-27F earnings by 13%, 6%, and 4%. Correspondingly, our DCF-derived TP drops to MYR0.88 (inclusive of a 2% ESG discount), which implies an unchanged 11x P/E FY26F. The valuation is below the consumer sector average, considering the highly regulated direct selling industry DXN is in.
Results review. YoY, 1HFY25 revenue rose 9% to MYR964m thanks to the robust sales growth in key markets, including Peru and Bolivia. That said, 1HFY25 EBITDA only grew 3% to MYR277m as a result of higher staff costs (+24% YoY) to accommodate expansion plans and elevated shipping rates. QoQ, 2QFY25 revenue rose 3% to MYR488m, similarly underpinned by steady performance in the key markets. However, 2QFY25 core net profit dipped 19% to MYR66m due to the cost inflations and charging of FX losses amounting to MYR21m. 1HFY25 DPS was 1.7 sen vs 1HFY24: 1.7sen.
Outlook. DXN’s earnings growth will be supported by the relentless growth momentum in major markets. Core strategies to recruit new members and enhance members’ productivity will continue to revolve around member engagements, complemented by quality of new product launches. Meanwhile, the recent capacity expansion should help capture the rising demand and roll out new product categories to broaden the addressable markets. In addition, the consequent efficiency gain, together with annual price adjustments, will sustain the high GPM of c.80% notwithstanding rising input and overhead costs. We also look forward to the results from the entry to Brazil, leveraging on DXN’s established existing network in the Latin American region. We expect significant earnings contribution from this venture in three to four years’ time.
Risks to our recommendation include major delays in expansion plans and unfavourable regulatory changes.
Source: RHB Research - 25 Oct 2024
2 days ago
dxn would report forex gain as USD rose sharply from usd1=rm4.1++ to rm4.5++ buy call
2 days ago
companies with huge sales from export or biz in usd would surge when they announce the results in the quarter where usd1 back to rm4.5++++++++++++++++++
2 days ago
good luck!
Assumptions for Optimistic Forecast:
General Trend: Based on the data, the overall trend has seen positive price shifts in some months (like +11.45%, +3.09%, etc.) and some declines. Optimistically, we will assume continued upward growth, with occasional corrections.
Growth Rate: We will forecast a steady positive growth rate for each year, assuming that the market continues to recover and show resilience in the future. The rate will be a bit higher than past growth averages to reflect the "optimistic" assumption.
Price Behavior: We will estimate that monthly prices will experience fluctuations of around +3% to +5% per year, and yearly growth will compound.
Price Forecast for 2025-2027 (Optimistic Scenario):
2025:
January 2025: $0.75 (starting from $0.50 in December 2024, assuming a 50% growth over the year)
June 2025: $0.85 (continuing positive momentum)
December 2025: $1.00 (optimistic growth of about 33% for the second half of the year)
2026:
January 2026: $1.05 (stable increase of around 5% from December 2025)
June 2026: $1.20 (strong growth from the first half of the year)
December 2026: $1.35 (continued growth, around 12% growth for the second half)
2027:
January 2027: $1.40 (slow but steady increase of 5%)
June 2027: $1.60 (stronger growth as market conditions improve, +15%)
December 2027: $1.80 (a final push to reach this price point, around +12% growth for the latter half of the year)
Key Assumptions:
The overall growth rate averages around 20-25% per year, based on the optimistic outlook.
Occasional dips or corrections of -5% to -10% could still occur in short bursts but are assumed to be short-lived.
This forecast assumes that the market conditions will be generally favorable in the coming years, with improving sentiment, potential recovery from global events, and increased investor confidence.
2 days ago
The continued revenue growth does indicate that DXN has strong market demand and an effective sales strategy
2 days ago
Here’s a summary of why DXN Holdings Berhad (DXN) could see its share price surge above RM 1:
Strong Market Position: Well-established brand in the global health and wellness sector, with growing demand for natural, herbal products.
Expansion into New Markets: Continued geographic expansion in high-growth regions like Asia, Europe, and Africa.
Product Diversification & Innovation: Introduction of new health products and diversification into areas like nutraceuticals and organic food.
Strong Financial Performance: Consistent revenue growth and improved profitability could increase investor confidence.
Strategic Partnerships: Potential partnerships with key players in the wellness industry could boost growth and distribution.
Increased Investor Interest: Positive market sentiment, including institutional investment, could drive demand for DXN shares.
Mergers & Acquisitions: Possible mergers or acquisitions could create synergies, increase revenue, and enhance market value.
Share Buybacks or Corporate Actions: Corporate actions like share buybacks could signal undervaluation and increase demand.
Industry Growth: Increasing global demand for health and wellness products could benefit DXN, particularly post-pandemic.
These factors together create strong growth potential, increasing the likelihood of the share price surpassing RM 1.
2 days ago
dividend yield 7.1%++ much higher than EPF ... take a look
dxn, good for retirees aiming at dividend .. 7.1%++ one of the best
10 hours ago
Good dividends + Potentially high returns on capital = DXN Holdings Berhad 😁
4 hours ago
7.1% yield is quite attractive actually, better than putting fd here and there, best you can get is also 4 like that only
1 hour ago
sweetpie
Try to grab at 0.40, in the dream perhaps. Now technically bullish d, no way to get it that low
3 weeks ago